XUE Jian-jun, FAN Qiang, YANG Li-xia, et al. Pathogenesis of Diabetic Cardiomyopathy and Overview Traditional Chinese Medicine Treatment[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(22): 211-217.
DOI:
XUE Jian-jun, FAN Qiang, YANG Li-xia, et al. Pathogenesis of Diabetic Cardiomyopathy and Overview Traditional Chinese Medicine Treatment[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(22): 211-217. DOI: 10.13422/j.cnki.syfjx.2017220211.
Pathogenesis of Diabetic Cardiomyopathy and Overview Traditional Chinese Medicine Treatment
Chronic complications of diabetes are mainly macrovascular disease and microvascular disease
in which microvascular disease is a diabetic-specific complication
with microcirculation disturbance and microvascular basement membrane thickening as the typical lesions. Specifically
heart microvascular disease and myocardial metabolic disorders can cause extensive myocardial necrosis
which is known as diabetic cardiomyopathy. The pathogenesis of diabetic cardiomyopathy is very complex
involving many aspects
including myocardial fibrosis
myocardial glucose and lipid metabolism
oxidative stress
cytokine abnormalities
insulin resistance
mitogen-activated protein kinase (AMPK) protein kinase and its associated protease signaling pathway
mammalian target of rapamycin (mTOR) signaling pathway
and NF-E2-related factor 2-antioxidant response element (Nrf2-ARE) signaling pathway. Traditional Chinese medicine(TCM) doctors mainly consider in the aspects of activating blood and unblocking collaterals
and focus on single herb and TCM compounds. A large number of animal experiments and clinical data show that TCMs have a good effect in the treatment of this disease. It is a very meaningful to bring TCM's characteristic of treatment based on syndrome differentiation
deeply dig Chinese herbal medicine resources
and apply its characteristics of composition and multiple dosage forms in the treatment of diabetic cardiomyopathy. This article reviews the pathogenesis of diabetic cardiomyopathy and the studies for prevention and treatment of TCM
and provides a reference for clinical prevention and treatment of this disease.
Pathogenesis and Drug Intervention of Diabetic Cardiomyopathy: A Review
Regulatory Mechanism of Traditional Chinese Medicine in Mitochondrial Quality Control for Diabetic Cardiomyopathy: A Review
Characteristic Analysis of Effective Components and Compounds of TCM for Prevention and Treatment of Breast Cancer Based on Wnt/β-catenin Signaling Pathway Targeting
Pathogenesis of Chronic Obstructive Pulmonary Disease and Modulating Effect of Traditional Chinese Medicine: A Review
Research Progress on Pathogenesis of Osteoporosis and Intervention of Traditional Chinese Medicine: A Review
Related Author
Hong-na TONG
Chen-yang ZHANG
Mei-xin HAN
Gui-bo SUN
Xiao-bo SUN
Mo CHEN
Ying-juan WEN
Huan ZHAO
Related Institution
Institute of Medicinal Plant Development,Chinese Academy of Medical Sciences and Peking Union Medical College
School of Pharmacy,Engineering Research Center for Medicine, Harbin University of Commerce
Shaanxi University of Chinese Medicine
Henan University of Chinese Medicine
Collaborative Innovation Center of Research and Development on the Whole Industry Chain of Yu-yao